Sequence Similarity Clusters for the Entities in PDB 1G9N

Entity #1 | Chains: G
ENVELOPE GLYCOPROTEIN GP120 protein, length: 313 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 7 10 3482
95 % 8 11 3642 Flexibility: Low
Max RMSD: 1.9, Avg RMSD: 1.0
PDBFlex
90 % 9 13 3020
70 % 93 200 130
50 % 93 200 152
40 % 93 200 165
30 % 93 203 182
Entity #2 | Chains: C
T-CELL SURFACE GLYCOPROTEIN CD4 protein, length: 185 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 23 40 869
95 % 25 46 820 Flexibility: Low
Max RMSD: 2.4, Avg RMSD: 1.2
PDBFlex
90 % 25 46 851
70 % 25 46 900
50 % 25 46 944
40 % 25 46 975
30 % 25 46 958
Entity #3 | Chains: L
ANTIBODY 17B, LIGHT CHAIN protein, length: 214 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 3 18252
95 % 22 34 1134 Flexibility: Low
Max RMSD: 5.3, Avg RMSD: 1.2
PDBFlex
90 % 587 857 2
70 % 1865 2747 1
50 % 3793 5577 1
40 % 4307 6322 1
30 % 5349 7862 1
Entity #4 | Chains: H
ANTIBODY 17B, HEAVY CHAIN protein, length: 229 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 19 26 1233
95 % 19 26 1472 Flexibility: Low
Max RMSD: 3.9, Avg RMSD: 1.0
PDBFlex
90 % 19 26 1498
70 % 1834 2706 2
50 % 3794 5577 1
40 % 4308 6322 1
30 % 5350 7862 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 4NZU 2 H 13PL light chain Fab 9606
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
5 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
6 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
7 1MEX 1 L Fab 29G12 light chain 10090
8 1MEX 2 H Fab 29G12 heavy chain 10090
9 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
10 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
11 4BUH 1 A, B CLONE M0418 SCFV 9606
12 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
13 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
14 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
15 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
16 5YD4 1 A, C, E, G scFv 4B08 10090
17 5YD3 1 A, C, E, G scFv 4B08 10090
18 5UD9 1 H Fab heavy chain 9606
19 5UD9 2 L Light chain 9606
20 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
21 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
22 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
23 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
24 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
25 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
26 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
27 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
28 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
29 6MEE 2 B, D antibody HEPC74 Light Chain 9606
30 6BJZ 1 H 5c8 Fab Heavy chain 9606
31 6BJZ 2 L 5c8 Fab Light chain 9606
32 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
33 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
34 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
35 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
36 4XCF 1 L 4E10 Fab light chain 9606
37 4XCF 2 H 4E10 Fab heavy chain 9606
38 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
39 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
40 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
41 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
42 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
43 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
44 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
45 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
46 5X08 1 H Fab 4E10 Heavy chain 9606
47 5X08 2 L Fab 4E10 Light chain 9606
48 6NB8 1 H S230 antigen-binding (Fab) fragment, heavy chain 9606
49 6NB8 2 L S230 antigen-binding (Fab) fragment, light chain 9606
50 6A76 1 L Light chain of the anti-human Robo1 antibody B5209B Fab 10090
51 6A76 2 H Heavy chain of the anti-human Robo1 antibody B5209B Fab 10090
52 6MEG 1 H antibody HEPC46 Heavy Chain 9606
53 6MEG 2 L antibody HEPC46 Light Chain 9606
54 4XAW 1 L 4E10 Fab light chain 9606
55 4XAW 2 H 4E10 Fab heavy chain 9606
56 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
57 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
58 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
59 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
60 5UCB 1 H Fab Heavy Chain 9606
61 5UCB 2 L Fab Light Chain 9606
62 2VXV 1 H HUMAN IGG ABT-325 9606
63 2VXV 2 L HUMAN IGG ABT-325 9606
64 4GXV 1 H, I Antibody 1F1, heavy chain 9606
65 4GXV 2 L, M Antibody 1F1, light chain 9606
66 2VXT 1 H MURINE IGG 125-2H 10090
67 2VXT 3 L MURINE IGG 125-2H 10090
68 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
69 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
70 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
71 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
72 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
73 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
74 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
75 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
76 5W24 1 L 5C4 Fab Light Chain 10090
77 5W24 2 H 5C4 Fab Heavy Chain 10090
78 4HPY 1 H CH59 Fab heavy chain 9606
79 4HPY 2 L CH59 Fab light chain 9606
80 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
81 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
82 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
83 4JG1 1 L Fab light chain 9606
84 4JG1 2 H Fab heavy chain 9606
85 6E65 1 L TB31F Fab light chain 9606
86 6E65 2 H TB31F Fab heavy chain 9606
87 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
88 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
89 5VF2 1 A scFv 2D10 10090
90 5I8C 1 A VRC34.01 Fab heavy chain 9606
91 5I8C 2 B VRC34.01 Fab light chain 9606
92 4O5L 1 L Fab F045-092 light chain 9606
93 4O5L 2 H Fab F045-092 heavy chain 9606
94 5MYX 1 A, C Fab c#24 light chain 10090
95 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
96 3IFL 1 L 12A11 FAB antibody light chain 10090
97 3IFL 2 H 12A11 FAB antibody heavy chain 10090
98 5WK2 1 L M116 LIGHT CHAIN 9606
99 5WK2 2 H M116 HEAVY CHAIN FD 9606
100 3PP4 1 H GA101 Fab heavy chain 10090
101 3PP4 2 L GA101 Fab light chain 10090
102 3KDM 1 A, L Immunoglobulin light chain 9606
103 3KDM 2 B, H Immunoglobulin heavy chain 9606
104 5NIV 1 A Light chain of 5D3 Fab 10090
105 5NIV 2 B Heavy chain of 5D3 Fab 10090
106 5N4J 1 L LIGHT CHAIN 9606
107 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
108 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
109 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
110 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
111 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
112 5X4G 1 A 6H8 Fab heavy chain 10090
113 5X4G 2 B 6H8 Fab light chain 10090
114 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
115 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
116 4PTU 1 A Antibody pn132p2C05, light chain 9606
117 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
118 4TPR 1 L If kappa light chain 10090
119 4TPR 2 H Fab heavy chain 10090
120 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
121 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
122 3IFN 1 H 12A11 FAB antibody heavy chain 10090
123 3IFN 2 L 12A11 FAB antibody light chain 10090
124 5U3P 1 H DH511.4 Fab Heavy Chain 9606
125 5U3P 2 L DH511.4 Fab Light Chain 9606
126 6BLA 1 H AMM01 Fab Heavy chain 9606
127 6BLA 2 L AMM01 Fab Light chain 9606
128 4TOY 1 H 35O22 Fab Heavy chain 9606
129 4TOY 2 L 35O22 Fab Light chain 9606
130 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
131 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
132 3NPS 2 B S4 FAB HEAVY CHAIN 9606
133 3NPS 3 C S4 FAB LIGHT CHAIN 9606
134 5I4F 1 A scFv 2D10 10090
135 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
136 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
137 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
138 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
139 5WN9 1 H scFv 2D10 9606
140 4XC3 1 L 4E10 Fab light chain 9606
141 4XC3 2 H 4E10 Fab heavy chain 9606
142 4M5Y 1 H, I Fab 5J8 heavy chain 9606
143 4M5Y 2 L, M Fab 5J8 light chain 9606
144 4TQE 1 L If kappa light chain 10090
145 4TQE 2 H Fab heavy chain 10090
146 5YY4 1 A scFv 4B08 10090
147 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
148 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
149 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
150 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
151 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
152 5VSI 2 L CH1/Ckappa Fab light chain 9606
153 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
154 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
155 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
156 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
157 5JXA 1 H VRC03 Heavy chain 9606
158 5JXA 2 L VRC03 Light chain 9606
159 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
160 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
161 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
162 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
163 3NTC 1 L Fab light chain 10090
164 3NTC 2 H Fab heavy chain 10090
165 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
166 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
167 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
168 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
169 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
170 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
171 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
172 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
173 6BE3 1 H Fab (F598) Heavy Chain 9606
174 6BE3 2 L Fab (F598) Light Chain 9606
175 4NWU 1 H APE1551 Ab Fab heavy chain 9606
176 4NWU 2 L APE1551 Ab Fab light chain 9606
177 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
178 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
179 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
180 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
181 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
182 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
183 5EWI 1 H VRC38.01 Heavy Chain 9606
184 5EWI 2 L VRC38.01 Light Chain 9606
185 5E2W 1 L AT8 LIGHT CHAIN 10090
186 5E2W 2 H AT8 HEAVY CHAIN 10090
187 5MYK 1 A Fab c#17 light chain 10090
188 5MYK 2 B Fab c#17 heavy chain 10090
189 4NZR 1 H PGT135 heavy chain Fab 9606
190 4NZR 2 L PGT135 light chain Fab 9606
191 5MYO 1 A, C Fab c#6 light chain 10090
192 5MYO 2 B, D Fab c#6 heavy chain 10090
193 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
194 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
195 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
196 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
197 5UEL 1 H 354NC102 Fab Heavy Chain 9606
198 5UEL 2 L 354NC102 Fab Light Chain 9606
199 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
200 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
201 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
202 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
203 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
204 5E2V 1 L AT8 LIGHT CHAIN 10090
205 5E2V 2 H AT8 HEAVY CHAIN 10090
206 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
207 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
208 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
209 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
210 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
211 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
212 5JUE 1 L light chain of UIC2 Fab 10090
213 5JUE 2 H heavy chain of UIC2 Fab 10090
214 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
215 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
216 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
217 5JR1 1 H 10E8 heavy chain 9606
218 5JR1 2 L 10E8 mature light chain 9606
219 6CA7 1 L PCT64_13C light chain 9606
220 6CA7 2 H PCT64_13C heavy chain 9606
221 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
222 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
223 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
224 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
225 5OB5 2 H fAb Heavy chain 9606
226 5OB5 3 L fAb Light chain 9606
227 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
228 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
229 5I66 1 A 8B6 antibody, heavy chain 10090
230 5I66 2 B 8B6 antibody, light chain 10090
231 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
232 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
233 6BZY 1 H 22D11 Heavy Chain 10090
234 6BZY 2 L 22D11 Light Chain 10090
235 3QQ9 1 C, L 101F LIGHT CHAIN 10090
236 3QQ9 2 D, H 101F HEAVY CHAIN 10090
237 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
238 5TKK 3 L mouse antibody vFP5.01 light chain 10090
239 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
240 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
241 5W6C 1 H UCA Fab heavy chain 9606
242 5W6C 2 L UCA Fab light chain 9606
243 5I1K 1 L FAB LIGHT CHAIN 9606
244 5I1K 2 H FAB HEAVY CHAIN 9606
245 3OZ9 1 L Fab NC-1 kappa light chain 10090
246 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
247 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
248 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
249 5V7U 1 L CBTAU-22.1 Fab light chain 9606
250 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
251 5UEA 1 A, H Fab Heavy Chain 9606
252 5UEA 3 B, L Fab Light Chain 9606
253 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
254 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
255 3G5Y 1 A 175 light chain 10090
256 3G5Y 2 B 175 heavy chain 10090
257 5NMV 1 L Fab light chain 10088
258 5NMV 2 H Fab heavy chain 10088
259 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
260 4N8C 2 L, M Light chain of monoclonal antibody 10090
261 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
262 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
263 4HGW 1 A Antibody Fab fragment, light chain 10090
264 4HGW 2 B Antibody Fab fragment, heavy chain 10090
265 1NLB 1 L antibody 19D9D6 light chain 10090
266 1NLB 2 H antibody 19D9D6 heavy chain 10090
267 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
268 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
269 3VFG 1 L 3F8 Light Chain 10090
270 3VFG 2 H 3F8 Heavy Chain 10090
271 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
272 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
273 3QRG 1 L Fab light chain 9606
274 3QRG 2 H Fab heavy chain Fd fragment 9606
275 5M6A 1 A, B, C, D Bence-Jones light chain 9606
276 4LLY 2 B, D light chain Clambda 9606
277 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
278 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
279 5EZI 1 H Fab c12 heavy chain 9606
280 5EZI 2 L Fab c12 Light chain 9606
281 4K23 1 H anti-uPAR antibody, heavy chain 10090
282 4K23 2 L anti-uPAR antibody, light chain 10090
283 3NCJ 1 L Fab15 Mut8 light chain 9606
284 3NCJ 2 H Fab15 Mut8 heavy chain 9606
285 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
286 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
287 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
288 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
289 5W05 1 L M59 FAB LIGHT CHAIN 10090
290 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
291 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
292 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
293 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
294 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
295 4M61 1 A, C Fab A52 light chain 10090
296 4M61 2 B, D Fab A52 heavy chain 10090
297 5YE3 1 B 2A7D9 VH CH1 chain 10090
298 5YE3 2 A 2A7D9 L chain 10090
299 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
300 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
301 1UM5 1 L Antibody 21H3 L chain 10090
302 1UM5 2 H Antibody 21H3 H chain 10090
303 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
304 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
305 4NWT 1 L APE1531 Ab Fab light chain 9606
306 4NWT 2 H APE1531 Ab Fab heavy chain 9606
307 3WHX 1 A mAb Fab H fragment 10090
308 3WHX 2 B mAb Fab L fragment 10090
309 3NA9 1 L Fab15 light chain 9606
310 3NA9 2 H Fab15 heavy chain 9606
311 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
312 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
313 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
314 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
315 4LRI 1 A, B MSL-109 Light Chain 9606
316 4LRI 2 C, P MSL-109 Heavy Chain 9606
317 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
318 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
319 4JN2 1 A, L anti dabigatran Fab 10090
320 4JN2 2 B, H anti dabigatran Fab 10090
321 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
322 4XBE 2 H 4E10 Fab heavy chain 9606
323 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
324 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
325 6BE2 1 H Fab (F598) Heavy Chain 9606
326 6BE2 2 L Fab (F598) Light Chain 9606
327 4JFZ 1 L Fab light chain 9606
328 4JFZ 2 H Fab heavy chain 9606
329 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
330 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
331 3WIF 1 A mAb Fab H fragment 10090
332 3WIF 2 B mAb Fab L fragment 10090
333 5U6A 1 A Light Chain 9606
334 5U6A 2 B Heavy Chain 9606
335 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
336 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
337 3MBX 1 L X836 LIGHT CHAIN 10090
338 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
339 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
340 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
341 6APC 1 H Epididymis luminal protein 214 9606
342 6APC 2 L IGL@ protein 9606
343 4HHA 1 A Fab KE5 Fab fragment KE5 9606
344 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
345 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
346 4RGO 2 H 14G8 heavy chain Fab 10090
347 4RGO 3 L 14G8 light chain Fab 10090
348 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
349 5GRY 1 A, G diabody 9606
350 5UEK 2 H Fab 12E Heavy Chain 9606
351 5UEK 3 L Fab 12E Light Chain 9606
352 3NAA 1 L Fab15 Mut5 light chain 9606
353 3NAA 2 H Fab15 Mut5 heavy chain 9606
354 1Q0X 1 L Fab 9B1, light chain 10090
355 1Q0X 2 H Fab 9B1, heavy chain 10090
356 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
357 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
358 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
359 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
360 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
361 5IK3 2 B, D 1E03 Fab fragment light chain 9606
362 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
363 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
364 5XLI 1 a, b FabL 10090
365 5XLI 2 c, d FabH 10090
366 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
367 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
368 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
369 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
370 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
371 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
372 4WUK 1 H CH65 heavy chain 9606
373 4WUK 2 L CH65 light chain 9606
374 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
375 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
376 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
377 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
378 5JOP 1 D, L Fab 14.22 light chain 10090
379 5JOP 2 E, H Fab14.22 heavy chain 10090
380 4HPO 1 H CH58 Fab heavy chain 9606
381 4HPO 2 L CH58 Fab light chain 9606
382 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
383 5UKN 2 L DH522UCA Fab fragment light chain 9544
384 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
385 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
386 5IT2 1 H heavy chain 9606
387 5IT2 2 L light chain 9606
388 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
389 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
390 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
391 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
392 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
393 5MO3 3 L Fab of monoclonal antibody, light chain 10090
394 5GZ0 1 A, C FM329 light chain 1383439
395 5GZ0 2 B, D FM329 heavy chain 1383439
396 6DW2 1 A 6078 Fab light chain 9606
397 6DW2 2 B 6078 Fab heavy chain 9606
398 6BQB 1 L MGG4 Fab light chain 9606
399 6BQB 2 H MGG4 Fab heavy chain 9606
400 4PUB 1 H DX-2930 HEAVY CHAIN 9606
401 4PUB 2 L DX-2930 LIGHT CHAIN 9606
402 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
403 6B14 2 L Light chain of Fab BL3-6S97N 10090
404 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
405 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
406 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
407 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
408 5GS3 1 A, H diabody protein 9606
409 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
410 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
411 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
412 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
413 5VKD 2 H Fab Heavy Chain 9606
414 5VKD 3 L Fab light chain 9606
415 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
416 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
417 5XHG 1 A, C polypeptide(L) 10090
418 5XHG 2 B, D polypeptide(H) 10090
419 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
420 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
421 3UYR 1 H antibody Fab heavy chain 10090
422 3UYR 2 L antibody Fab light chain 10090
423 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
424 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
425 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
426 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
427 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
428 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
429 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
430 3OAZ 2 K, L Fab 2G12, light chain 9606
431 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
432 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
433 1ZAN 1 L Fab AD11 Light Chain 10116
434 1ZAN 2 H Fab AD11 Heavy Chain 10116
435 6CJK 1 A, C Immunoglobulin Fab light chain 9986
436 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
437 4N0Y 1 H IGH526 Heavy Chain 9606
438 4N0Y 2 L IGH526 Light Chain 9606
439 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
440 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
441 5MTH 1 A, H antibody Fab heavy chain 10090
442 5MTH 2 B, L antibody Fab light chain 10090
443 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
444 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
445 1RZF 1 L Fab E51 light chain 9606
446 1RZF 2 H Fab E51 heavy chain 9606
447 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
448 4KTE 2 L GE148 Light Chain Fab 9544
449 5I8O 1 H HMM5 antibody heavy chain 9606
450 5I8O 2 L HMM5 antibody light chain 9606
451 4JG0 1 L Fab light chain 9606
452 4JG0 2 H Fab heavy chain 9606
453 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
454 4YGV 2 B, L aDabi-Fab2a light chain 9606
455 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
456 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
457 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
458 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
459 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
460 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
461 3EO0 1 A, C GC-1008 Fab Light Chain 10090
462 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
463 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
464 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
465 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
466 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
467 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
468 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
469 4FQI 3 H antibody CR9114 heavy chain Fab 9606
470 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
471 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
472 4JHA 2 L D25 light chain 9606
473 6B9Z 1 A Trastuzumab Fab light chain 10090
474 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
475 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
476 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
477 4PTT 1 A Antibody pn132p2C05, light chain 9606
478 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
479 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
480 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
481 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
482 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
483 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
484 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
485 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
486 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
487 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
488 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
489 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
490 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
491 4DGV 1 H HCV1 Heavy Chain Fab 9606
492 4DGV 2 L HCV1 Light Chain 9606
493 6C5K 1 A, H IgG1 Fab Heavy Chain 10090
494 6C5K 2 B, L IgG1 Fab Light Chain (Kappa) 10090
495 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
496 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
497 5TH2 1 A, C cetuximab Fab, light chain 10090
498 5TH2 2 B, D cetuximab Fab, heavy chain 10090
499 5I8K 1 L HHH1 Fab Light chain 9606
500 5I8K 2 H HHH1 Fab Heavy chain 9606
501 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
502 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
503 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
504 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
505 1YNL 1 L Ig gamma light chain 10090
506 1YNL 2 H Ig gamma heavy chain 10090
507 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
508 5EPM 2 B, F Antibody Fab fragment light chain 10090
509 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
510 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
511 3UMT 1 A scFv heavy chain and light chain 10090
512 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
513 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
514 4NUJ 1 A PGT152 light chain 9606
515 4NUJ 2 B PGT152 heavy chain 9606
516 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
517 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
518 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
519 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
520 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
521 3U2S 2 B, L PG9 light chain 9606
522 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
523 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
524 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
525 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
526 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
527 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
528 4NUG 1 L PGT151 light chain 9606
529 4NUG 2 H PGT151 heavy chain 9606
530 3IU4 1 H chP3 Fab heavy chain 10090
531 3IU4 2 L chP3 Fab light chain 10090
532 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
533 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
534 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
535 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
536 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
537 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
538 1P7K 1 A, L antibody light chain FAB 10090
539 1P7K 2 B, H antibody heavy chain FAB 10090
540 3RVV 2 C 4C1 - light chain 10090
541 3RVV 3 D 4C1 - heavy chain 10090
542 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
543 3P0Y 2 H Fab DL11 heavy chain 9606
544 3P0Y 3 L Fab DL11 light chain 9606
545 4NPY 1 A, L germline PGT121 light chain Fab 9606
546 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
547 6ANA 2 H LL2 Fab Heavy Chain 10090
548 6ANA 3 L LL2 Fab Light Chain 10090
549 5IBU 1 B, L 6652 Light Chain 9606
550 5IBU 2 G, H 6652 Heavy Chain 9606
551 5VPL 2 C 4C1 - LIGHT CHAIN 10090
552 5VPL 3 D 4C1 - HEAVY CHAIN 10090
553 6AOD 1 A FXIa Antibody FAB Light Chain 9606
554 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
555 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
556 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
557 2YPV 2 H FAB 12C1 10090
558 2YPV 3 L FAB 12C1 10090
559 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
560 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
561 4JY5 1 L PGT122 light chain Fab 9606
562 4JY5 2 H PGT122 heavy chain Fab 9606
563 6ELE 1 A, H fAB heavy chain 9606
564 6ELE 2 B, L fAB light chain 9606
565 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
566 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
567 6B5R 1 H CIS42 Fab Heavy chain 9606
568 6B5R 2 L CIS42 Fab Light chain 9606
569 3NAC 1 L Fab15 Mut7 light chain 9606
570 3NAC 2 H Fab15 Mut7 heavy chain 9606
571 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
572 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
573 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
574 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
575 1Q72 1 L Fab M82G2, Light chain 10090
576 1Q72 2 H Fab M82G2, Heavy chain 10090
577 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
578 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
579 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
580 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
581 4YHO 1 H aDabi-Fab3 heavy chain 9606
582 4YHO 2 L aDabi-Fab3 light chain 9606
583 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
584 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
585 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
586 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
587 4DGY 1 H HCV1 Heavy Chain Fab 9606
588 4DGY 2 L HCV1 Light Chain 9606
589 5EN2 1 A GD01 heavy chain 10090
590 5EN2 2 B GD01 light chain 10090
591 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
592 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
593 3MXW 2 L 5E1 light chain 9606
594 3MXW 3 H 5E1 heavy chain 9606
595 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
596 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
597 3EO9 1 L Efalizumab Fab fragment, light chain 9606
598 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
599 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
600 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
601 6N35 1 K, L Fab 2G12 light chain 9606
602 6N35 2 H, M Fab 2G12 heavy chain 9606
603 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
604 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
605 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
606 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
607 5WUV 1 L light chain 9606
608 5WUV 2 H heavy chain 9606
609 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
610 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
611 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
612 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
613 4JM4 1 H PGT 135 Heavy Chain Fab 9606
614 4JM4 2 L PGT 135 Light Chain Fab 9606
615 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
616 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
617 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
618 5YE4 2 B, D 1A9D7 L chain 10090
619 6B0G 1 C 1245 Antibody, Light Chain 9606
620 6B0G 2 D 1245 Antibody, Heavy Chain 9606
621 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
622 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
623 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
624 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
625 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
626 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
627 6D0X 1 A 2140 Antibody, heavy chain 9606
628 6D0X 2 B 1210 Antibody, light chain 9606
629 6BE4 1 H Fab (F598) Heavy Chain 9606
630 6BE4 2 L Fab(F598) Light Chain 9606
631 5TPP 1 L DH270.5 Fab heavy chain 9606
632 5TPP 2 H DH270.5 Fab light chain 9606
633 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
634 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
635 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
636 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
637 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
638 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
639 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
640 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
641 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
642 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
643 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
644 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
645 5TL5 1 L M2177 LIGHT CHAIN 10090
646 5TL5 2 H M2177 HEAVY CHAIN 10090
647 2FX7 1 L Fab 4E10 Light Chain 9606
648 2FX7 2 H Fab 4E10 Heavy Chain 9606
649 5Y9K 1 L belimumab light chain 9606
650 5Y9K 2 H belimumab heavy chain 9606
651 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
652 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
653 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
654 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
655 3WFH 1 A mAb Fab H fragment 10090
656 3WFH 2 B mAb Fab L fragment 10090
657 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
658 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
659 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
660 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
661 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
662 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
663 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
664 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
665 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
666 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
667 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
668 5HI4 3 D, L CAT-2000 FAB light chain 9606
669 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
670 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
671 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
672 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
673 3RVW 2 C 4C1 - light chain 10090
674 3RVW 3 D 4C1 - heavy chain 10090
675 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
676 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
677 5XKU 2 B HNIgGA6 light chain 9606
678 5XKU 3 C HNIgGA6 heavy chain 9606
679 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
680 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
681 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
682 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
683 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
684 5HI5 3 D, L CAT-2000 light chain 9606
685 5JO5 1 A, C, E, H 10E8 gHV 9606
686 5JO5 2 B, D, F, L 10E8 gLV 9606
687 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
688 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
689 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
690 5CCK 2 L Antibody 3BC315 Fab light chain 9606
691 5I76 1 A, C FM318_light_chain 1383439
692 5I76 2 B, D FM318_heavy_cahin 1383439
693 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
694 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
695 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
696 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
697 5I18 1 L FAB LIGHT CHAIN 9606
698 5I18 2 H FAB HEAVY CHAIN 9606
699 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
700 4JN1 2 L anti-dabigatran Fab1, light chain 10090
701 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
702 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
703 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
704 4G5Z 2 L canakinumab antibody fragment light chain 9606
705 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
706 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
707 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
708 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
709 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
710 2OK0 2 L Fab ED10 light chain 10090
711 2OK0 3 H Fab ED10 heavy chain 10090
712 3SOB 1 L antibody light chain 9606
713 3SOB 3 H antibody heavy chain 9606
714 6B5M 1 H CIS43 Fab Heavy chain 9606
715 6B5M 2 L CIS43 Fab Light chain 9606
716 5AWN 1 H Heavy chain of 3BC176 Fab 9606
717 5AWN 2 L Light chain of 3BC176 Fab 9606
718 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
719 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
720 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
721 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
722 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
723 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
724 5DR5 2 L AbD09097 Fab light chain 9606
725 2IH3 1 A FAB Heavy Chain 10090
726 2IH3 2 B FAB Light Chain 10090
727 4KQ3 1 L CNTO3186 light chain Fab 9606
728 4KQ3 2 H CNTO3186 heavy chain Fab 9606
729 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
730 6AQ7 3 L POM6 FAB light CHAIN 10090
731 4JFX 1 A, L Fab light chain 9606
732 4JFX 2 B, H Fab heavy chain 9606
733 3SGE 1 I, L Light Chain 10090
734 3SGE 2 H, J Heavy Chain 10090
735 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
736 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
737 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
738 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
739 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
740 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
741 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
742 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
743 5FHB 1 H Antibody 100 Fab heavy chain 9606
744 5FHB 2 L Antibody 100 Fab light chain 9606
745 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
746 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
747 1JGU 1 L Antibody Light Chain 10090
748 1JGU 2 H Antibody Heavy Chain 10090
749 4I77 1 H Lebrikizumab heavy chain Fab 9606
750 4I77 2 L Lebrikizumab light chain Fab 9606
751 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
752 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
753 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
754 4O4Y 2 H 2095-2 heavy chain 9986
755 5OBF 1 H fAb Heavy chain 10090
756 5OBF 2 L fAb Light chain 10090
757 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
758 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
759 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
760 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
761 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
762 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
763 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
764 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
765 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
766 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
767 5MHE 1 L Fab-fragment 10090
768 5MHE 2 H Fab-fragment 10090
769 5YFI 1 L Light chain of Fab fragment 10090
770 5YFI 2 H Heavy chain of Fab fragment 10090
771 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
772 4GLR 3 I, K anti-ptau light chain light chain 9031
773 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
774 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
775 4HJG 1 A Trastuzumab light chain 9606
776 4HJG 2 B Trastuzumab heavy chain 9606
777 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
778 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
779 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
780 5I30 1 L Fab PL-2 light chain 10090
781 5I30 2 H Fab PL-2 heavy chain 10090
782 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
783 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
784 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
785 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
786 6CT7 1 B, L BIIB054 Fab light chain 9606
787 6CT7 2 A, H BIIB054 Fab heavy chain 9606
788 3FN0 1 L Fab Z13e1 light chain 9606
789 3FN0 2 H Fab Z13e1 heavy chain 9606
790 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
791 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
792 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
793 4YHI 2 B, L aDabi-Fab2a light chain 9606
794 5NYX 1 H, M, O HEAVY CHAIN CHAIN H AND O ARE TWO SEPARATE POLYPEPTIDE CHAINS. fab heavy chains. The sequence provided contains the cleavable strep tag that has been removed prior to crystallisation 9606
795 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
796 4OSU 1 H SM5-1 Fab Heavy Chain 9606
797 4OSU 2 L SM5-1 Fab Light Chain 9606
798 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
799 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090
800 5IFA 1 H VRC01c-HuGL2 Fab heavy chain 9606
801 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
802 1T2Q 1 L Fab NNA7 Heavy Chain 10090
803 1T2Q 2 H Fab NNA7 Light Chain 10090
804 6ELJ 1 A, H fAB heavy chain 9606
805 6ELJ 2 B, L fAB light chain 9606
806 4G6K 1 H heavy chain of gevokizumab antibody binding fragment 10090
807 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
808 4MAU 1 L C2244 light chain SEE REMARK 999 10090
809 4MAU 2 H C2244 heavy chain FD, SEE REMARK 999 10090
810 3LEX 1 A, H 11f10 Antibody Heavy Chain 10090
811 3LEX 2 B, L 11f10 Antibody Light Chain 10090
812 6B0W 1 L 1710 antibody, light chain 9606
813 6B0W 2 H 1710 antibody, heavy chain 9606
814 5VH4 1 A, H Infliximab Fab Heavy Chain 10090
815 5VH4 2 B, L Infliximab Fab Light Chain 10090
816 5DQD 1 L S55-5 Fab (IgG1 kappa) light chain 10090
817 5DQD 2 H S55-5 Fab (IgG1) heavy chain 10090
818 5DT1 1 H Fab Heavy chain of broadly neutralizing antibody VRC26.25 9606
819 5DT1 2 L Fab Light chain of broadly neutralizing antibody VRC26.25 9606
820 4ONF 1 H 3D6 FAB ANTIBODY HEAVY CHAIN 10090
821 4ONF 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090
822 1OPG 1 L OPG2 FAB (LIGHT CHAIN) 9606
823 1OPG 2 H OPG2 FAB (HEAVY CHAIN) 9606
824 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
825 1JPS 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
826 5NPJ 1 A, B Single chain variable fragment of the non-neutralizing antibody DAO5 10090
827 1NBY 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090
828 1NBY 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-63 10090
829 3V6O 2 C, D Monoclonal antibody 9F8 fab fragment Heavy chain Fab fragment of monoclonal antibody H chain 10090
830 3V6O 3 E, F Monoclonal antibody 9F8 fab fragment Light chain Fab fragment of monoclonal antibody L chain 10090
831 3S96 1 A, C 3B5H10 FAB heavy chain 10090
832 3S96 2 B, D 3B5H10 FAB light chain 10090
833 6CBV 1 H Heavy chain, Fab fragment 9606
834 6CBV 2 L Light Chain, Fab fragment 9606
835 4LKX 1 A Fab fragment heavy chain 9606
836 4LKX 2 B Fab fragment light chain 9606
837 1Q9O 1 B, D S45-2 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
838 1Q9O 2 A, C S45-2 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
839 3SE8 2 H Heavy chain of antibody VRC03 Antigen binding fragement of antibody heavy chain 9606
840 3SE8 3 L Light chain of antibody VRC03 antibody light chain 9606
841 5JW5 1 A, H MEDI8852 Heavy chain 9606
842 5JW5 2 B, L MEDI8852 Light chain 9606
843 5VH3 1 A, H Infliximab Fab Heavy Chain 10090
844 5VH3 2 B, L Infliximab Fab Light Chain 10090
845 6DCV 1 A, L Light chain of CBTAU27.1 Fab 9606
846 6DCV 2 B, H heavy chain of CBTAU-27.1 Fab 9606
847 5HDQ 2 H Fab Heavy Chain 10090
848 5HDQ 3 L Fab Light Chain 10090
849 4FQ2 1 H Fab heavy chain 9606
850 4FQ2 2 L Fab light chain 9606
851 3RKD 2 C, L Monoclonal Antibody, Light Chain 10090
852 3RKD 3 D, H Monoclonal Antibody, Heavy Chain 10090
853 3L1O 1 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 H CHAIN 10090
854 3L1O 2 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 L CHAIN 10090
855 2A77 1 L Immunoglobulin Light Chain 10090
856 2A77 2 H Immunoglobulin Heavy Chain 10090
857 2FB4 1 L IGG1-LAMBDA KOL FAB (LIGHT CHAIN) 9606
858 2FB4 2 H IGG1-LAMBDA KOL FAB (HEAVY CHAIN) 9606
859 3GO1 1 L Fab 268-D, light chain 9606
860 3GO1 2 H Fab 268-D, heavy chain 9606
861 1F3D 1 J, L CATALYTIC ANTIBODY 4B2 LIGHT CHAIN - FAB FRAGMENT 10090
862 1F3D 2 H, K CATALYTIC ANTIBODY 4B2 HEAVY CHAIN - FAB FRAGMENT 10090
863 3QWO 1 B, L motavizumab light chain 10090
864 3QWO 2 A, H motavizumab heavy chain 10090
865 3CVI 1 H 25-D1.16 Heavy chain 10090
866 3CVI 2 L 25-D1.16 Light chain 10090
867 1PZ5 1 A Light chain of Fab (SYA/J6) 10090
868 1PZ5 2 B Heavy chain of Fab (SYA/J6) 10090
869 1LK3 2 L, M 9D7 Light Chain Fab fragment, Residues 1-210 10116
870 1LK3 3 H, I 9D7 Heavy Chain Fab fragment, Residues 1-219 10116
871 4IOI 1 A Trastuzumab light chain 9606
872 4IOI 2 B Trastuzumab heavy chain 9606
873 1N7M 1 H Germline Metal Chelatase Catalytic Antibody, chain H 10090
874 1N7M 2 L Germline Metal Chelatase Catalytic Antibody, chain L 10090
875 4OKV 1 A, C heavy chain of 8H7 mAb 10090
876 4OKV 2 B, D light chain of 8H7 mAb 10090
877 6GHG 1 A, H Fab heavy chain 9606
878 6GHG 2 B, L Fab light chain 9606
879 6B5S 1 H CIS42 Fab Heavy chain 9606
880 6B5S 2 L CIS42 Fab Light chain 9606
881 5K8A 1 A, E, L, M humanized Fab Lite chain 10090
882 5K8A 2 B, F, H, V Heavy chain 10090
883 5WKZ 1 H Immunoglobulin heavy variable 1-69D,IgG H chain 9606
884 5WKZ 2 L Lambda-chain (AA -20 to 215) 9606
885 1JGV 1 L Antibody Light Chain 10090
886 1JGV 2 H Antibody Heavy Chain 10090
887 5VAG 2 B Light chain of antibody m826 9606
888 5VAG 3 C Heavy chain of antibody m826 9606
889 3MLX 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
890 3MLX 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
891 3I9G 1 H Sonepcizumab antibody Fab fragment, heavy chain Fab Fragment 10090
892 3I9G 2 L Sonepcizumab antibody Fab fragment, light chain Fab Fragment 10090
893 5GIR 1 A, H Heavy chain of Fab fragment 10090
894 5GIR 2 B, L Light chain of Fab fragment 10090
895 6C5I 1 H Fab IgG1 Heavy Chain 10090
896 6C5I 2 L Fab IgG1 (kappa) Light Chain 10090
897 2ADF 2 H 82D6A3 IgG FAB 10090
898 2ADF 3 L 82D6A3 IgG FAB 10090
899 5I16 1 A, L FAB LIGHT CHAIN 9606
900 5I16 2 B, H FAB HEAVY CHAIN 9606
901 3O41 1 B, L Mouse monoclonal antibody 101F Fab light chain 10090
902 3O41 2 A, H Mouse monoclonal antibody 101F Fab heavy chain 10090
903 5F9O 2 H CH235.9 Heavy chain 9606
904 5F9O 3 L CH235.09 Light chain 9606
905 3Q6G 1 L, M Light chain of Fab of rhesus mAb 2.5B 9544
906 3Q6G 2 H, I Heavy chain of Fab of rhesus mAb 2.5B 9544
907 1UM4 1 L Antibody 21H3 L chain 10090
908 1UM4 2 H Antibody 21H3 H chain 10090
909 5VJQ 1 A, C, E, G HyHEL10 heavy chain Fab fragment carrying three mutations; I29F, S52T, Y53F DEL-I 10090 3.2.1.18 | Details
910 5VJQ 2 B, D, F, H HyHEL10 light chain Fab fragment 10090
911 4RBP 1 K, L Fab 2G12 light chain 9606
912 4RBP 2 H, M Fab 2G12 heavy chain 9606
913 3I75 1 A Antibody heavy chain 10090
914 3I75 2 B Antibody light chain 10090
915 4XVS 1 H VRC07_1995 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 Heavy chain 9606
916 4XVS 2 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 Light chain 9606
917 7FAB 1 L IGG1-LAMBDA NEW FAB (LIGHT CHAIN) 9606
918 7FAB 2 H IGG1-LAMBDA NEW FAB (HEAVY CHAIN) 9606
919 4FQL 1 H monoclonal antibody CR8033 heavy chain Fab 9606
920 4FQL 2 L monoclonal antibody CR8033 light chain Fab 9606
921 1NGX 1 A, L Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
922 1NGX 2 B, H Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
923 1E6O 1 H IMMUNOGLOBULIN HEAVY CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') HEAVY CHAIN 1-219 10090
924 1E6O 2 L IMMUNOGLOBULIN LIGHT CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') LIGHT CHAIN 1-210 10090
925 5GIS